Home / Inspections / 1031602

FDA Inspection 1031602 — Norman Latov, MD

Norman Latov, MD — FEI 3013977006

The FDA completed an inspection of Norman Latov, MD on Oct 26, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 26, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.